Dr. Frederick Robert Lane, MD

Dr. Lane practices at Franciscan Health Indianapolis Nuclear Cardiology - in Ihp Nuc Diag - HOPD in Indianapolis, Indiana.

Dr. Lane's NPI, 1376507103, was assigned on April 17, 2006. Dr. Lane graduated from Indiana University School Of Medicine in 1983. Dr. Lane's Indiana license number on file is 01037114.

Dr. Lane's primary practice is Franciscan Health Indianapolis Nuclear Cardiology - in Ihp Nuc Diag - HOPD, at 5255 E Stop 11 Rd, Indianapolis, IN 46237.

Dr. Lane's primary practice is Franciscan Health Indianapolis Nuclear Cardiology - in Ihp Nuc Diag - HOPD in Indianapolis, Indiana. Dr. Lane is also affiliated with Franciscan Health Indianapolis. The medical group on file is Franciscan Physician Network. Dmand AI also links Dr. Lane to 2 more hospitals, 1 group practice or clinic and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lane practices, 6 sites in all. Vendor and product names are available with a free account.

Colon and rectal surgery is Dr. Lane's primary specialty in the NPI Registry, under taxonomy code 208C00000X. Dr. Lane is board certified in colon & rectal surgery by the American Board of Colon and Rectal Surgery. Dmand AI has Dr. Lane's licenses on file in 2 states: Indiana and Michigan.

Dmand AI lists colonoscopy, colon removal and hemorrhoids among the conditions Dr. Lane treats.

CMS data shows 532 Medicare services from Dr. Lane across 15 procedure codes in 2024, for 341 Medicare patients. Medicare paid $61,450 for them.

CMS counts 341 Medicare patients who saw Dr. Lane in 2024. The largest group is 65 to 74, with 212 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.13, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lane's median patient age at 69, with 52% women.

In 2024, Dr. Lane wrote 367 Medicare Part D claims for 164 patients. 83% of them were for generic drugs. CMS names the drug for 278 of them, across 12 drugs with 11 or more claims each, at $15,643 in total drug cost. In 2023, CMS named 318 claims across 12 drugs.

Dr. Lane accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 95 procedures of colonoscopy by Dr. Lane, more than 79% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Lane, published from 2017 to 2021. 2021 was the busiest year, with 2. The most frequent topics are Postoperative Complications, Colectomy and Laparoscopy. Dr. Lane has published most often in Am J Surg. Dr. Lane's most frequent co-authors are Scott Dolejs, MD, Dipen Champaklal Maun, MD and Tobi Jean Reidy, DO.

Dmand AI links Dr. Lane to 1 clinical trial.

CMS Open Payments shows 138 general payments to Dr. Lane from 28 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 70% of the total. Merck Sharp & Dohme Corporation paid the most, $27,537. It also lists 2 research payments totaling $102 in 2019.

Dmand AI lists 3 awards for Dr. Lane, most recently CMS Stage 1 EHR in 2013.

Dr. Lane graduated from Indiana University School Of Medicine in 1983. Dr. Lane is a member of ACS.

Dr. Lane is in network with 15 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.